Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

Novel Medications for OCD

  • Broadcast in Health
Columbia Psychiatry NYSPI

Columbia Psychiatry NYSPI

×  

Follow This Show

If you liked this show, you should follow Columbia Psychiatry NYSPI.
h:592239
s:6888925
archived

Speaker

Carolyn Rodriguez, MD, PhD, Assistant Professor of Clinical Psychiatry, Columbia University Department of Psychiatry; NIMH Research Fellow, Center for OCD and Related Disorders at Columbia Psychiatry

Marcia Kimeldorf, PhD, Research Project Manager for OCD studies in the Anxiety Disorders Clinic will be the moderator

In this talk, Dr. Rodriguez will discuss how glutamate, the main excitatory chemical messenger in our brain, plays a role in OCD symptoms. Novel drugs thought to alter levels of glutamate are in development in our clinic and might hold the key to rapid symptom relief. 

Contact Information

For more information on OCD treatment and research opportunities for adults, please visit our clinic website at www.Columbia-OCD.org and our treatment study website at http://ocdtreatmentstudy.com/ or call us at 646 774-8062

For more information on OCD treatment and research opportunities for children and adolescents, please visit our website http://columbiapsychiatry.org/pamrc or call us at 646 774-5792

Comments